Evaluation of a novel sputum clearance technique—hydro-acoustic therapy (HAT) in adult patients with cystic fibrosis: A feasibility study

Abstract

This study was designed to investigate the efficacy, safety and patients’ acceptance of a novel system for sputum clearance—Hydro Acoustic Therapy (HAT) in patients with cystic fibrosis (CF). This is a prospective crossover study where 18 patients received 6 sessions of physiotherapy over 6 separate days. These consisted of 2 sessions of either HAT, flutter valve or and sitting in the bath with sounds without vibration (placebo) for 30 minutes each. The efficacy was investigated by measuring the weight of wet and dry sputum after each session and by change in spirometry values. The preference was assessed by a questionnaire completed by patients at the end of the study about their preference of which type of physiotherapy received. The weight of both dry and wet sputum produced was similar in the 3 arms of the study. Spirometry values but not oxygen saturation were reduced after HAT and flutter therapy sessions. HAT therapy was preferred to flutter and placebo in terms of breathlessness, ease of sputum production and relaxation. Of the patients, 70% stated that they would choose HAT as their preferred physiotherapy method compared to 0% for flutter (χ² = 20.3, p < 0.0001). There were no procedure-related complications in any of the 3 arms of the study. HAT was found to be safe, well tolerated and favoured by the majority of CF patients. The effect of HAT, however, on sputum production was not superior to flutter or placebo.

Keywords

cystic fibrosis physiotherapy hydro-acoustic therapy spirometry sputum clearance

References

Cohn LA , Weber A. , Phillips T. , Lory S. , Kaplan M. , and Smith A. Pseudomonas aeruginosa infection of respiratory epithelium in a cystic fibrosis xenograft model. J Infect Dis 2001; 183: 919-927.

Pier GB , Grout M. , Zaidi TS , and Goldberg JB How mutant CFTR may contribute to pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Crit Care Med 1996; 154: S175-S182.

Gibson RL , Burns JL , and Ramsay BW Pathophysiology and management of pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 2003; 68: 918- 951.

Goerke C. , Kraning K. , Stern M. , Doring G. , Botzenhart K. , and Wolz C. Molecular epidemiology of community-acquired staphylococcus aureus in families with and without cystic fibrosis patients. J infect Dis 2000; 181: 984-989.

Jarad NA , Higgs S. , Jeffcote T. , and Giles K. Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area. Chron Respir Dis 2005; 2: 133-137.

Jarad NA , Giles K. Risk factors for increased need for intravenous antibiotics for pulmonary exacerbations in adult patients with cystic fibrosis. Chron Respir Dis 2008; 5: 1-5.

van der Schans CP , Prasad A. , and Main E. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst Rev 2000; 2: CD001401.

Nelson R. , Miller S. , Hall D. , and Clayton B. Chest physiotherapy in cystic fibrosis. Thorax 1995; 50: 1123-1124.

Thomas J. , Cook DJ , and Brooks D. Chest Physical therapy management of patients with cystic fibrosis: a meta analysis. Am J Respir Crit Care Med 1995; 151: 845-850.

10.

Main E. , Prasad A. , and van der Schans CP Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005; 25: CD002011.

11.

Elkins M. , Jones A. , and van der Schans CP Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2006; 19: CD003147.

12.

Williams MT

Chest physiotherapy and cystic fibrosis: why is the most effective form of treatment still unclear?

Chest 1994; 106: 1872-1882.

13.

Abbott J. , Dodd M. , Bilton D. , and Webb AK Treatment compliance in adults with cystic fibrosis. Thorax 1994; 49: 115-120.

14.

Ramsey BW , Astley SJ , Aitken ML , et al. Efficacy and safety of short term administration of aerolised recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993; 148: 145-151.

15.

Ranasinha C. , Assoufi B. , Shak S. , et al. Efficacy and safety of short-term administration of aerolised recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet 1993; 342: 199-202.

16.

Elkins MR , Robinson M. , Rose BR , Harbour C. , et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354: 229-240.

17.

Robinson M. , Daviskas E. , Eberl S. , Baker J. , Chan HK , Anderson SD , et al. The effect of inhaled mannitol on bronchial mucous clearance in cystic fibrosis patients: a pilot study. Eur Respir J 1999; 14: 678-685.

18.

Alteirac L. Clinical trial of hydro acoustic therapy and conception of a second generation hydro acoustic chamber. Master’s Thesis. Georgia Institute of Technology, July 2001.

19.

Rogers PH , Caille GW , and Lewis TN Response of the lungs to low frequency underwater sound. Final Report for Navy Contract 1994 N00014-93-1-1263, Georgia Institute of Technology, Atlanta, GA.

20.

Stevens CC , Schilichting CL , and Baran F. Effects of low frequency water borne sound on divers: physiological monitoring during torso exposure. Presented at Naval Submarine Medical Research Laboratory Meeting on Effects of low frequency water -borne sound on divers, Naval Submarine Base, Groton, CT, 29 June 1994.

21.

Miller S. , Hall DO , Clayton CB , and Nelson R. Chest Physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995; 50: 165-169.

22.

Chatham K. , Ionescu AA , Nixon LS , and Shale DJ A short term comparison of two methods of sputum expectoration in cystic fibrosis . Eur Respir J 2004; 23: 435-439.

23.

Bhowmik A. , Seemungal TR , Sapsford RJ , Devalia JL , and Wedzicha JA Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53: 953-956.

24.

Pryor JA , Webber BA , Hodson ME , and Batten JC Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J 1979; 2: 417-418.

25.

App EM , Kieselmann R. , Reinhardt D. , Lindermann H. , Dasgupta B. , King M. , et al. Sputum rheuology changes in cystic fibrosis lung disease following two different types of physiotherapy. Chest 1998; 114: 171-177.

26.

Pryor JA , Webber BA , Hodson ME , and Warner JO The flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. Respir Med 1994; 88: 677-681.